- Lobbying
- WILLIAM AND CRONIN
Lobbying Arrangements Results for 'William Cronin'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details FDA regulation of Drugs and/or Medical Devices (S. 3187 FDA Safety and Innovation Act, HR FDA Reform Act of 2012). Issues related to drugs and/or medical devices that affect fees, inspections and ... |
BAUSCH & LOMB
|
POLICY DIRECTIONS INC. | |||
Details Pre-clinical research models and drug discovery, development and testing. Animal models and research animal issues and policies. |
CHARLES RIVER LABORATORIES
|
POLICY DIRECTIONS INC. | |||
Details Preventing Abuse of Cough Medicine. HR 3250 - DXM Abuse Prevention Act of 2015. S. 697 Lautenberg Chemical Safety Act. S. 725 Toxic Chemical Protection Act. S. 1424, HR 1331 Microbeads-Free Waters ... |
RECKITT BENCKISER LLC (formerly known as Reckitt Benckiser)
|
POLICY DIRECTIONS INC. | |||
Details Implementation of S. 510, The Food Safety Modernization Act, with emphasis on those titles related to the inspection and third party testing of imported and domestic food ingredients. Medical and c... |
COVANCE, INC.
|
POLICY DIRECTIONS INC. | |||
Details Development of opioid pain management products. Abuse deterrent technology for opioid analgesics. |
QRxPHARMA LIMITED
|
POLICY DIRECTIONS INC. | |||
Details FDA Modernization of Cosmetics. FY16 Agriculture Appropriations; FDA Appropriations related to funding for the Office of Cosmetics and Colors within CFSAN. S. 1424, H.R. 1331 Microbeads-Free Waters... |
PERSONAL CARE PRODUCTS COUNCIL
|
POLICY DIRECTIONS INC. | |||
Details Health care issues including Medicare's long-term financial health and drivers of health insurance premium changes, and comments on proposed legislation to add a long-term care benefit to the Medic... |
American Academy of Actuaries
|
in-house lobbying | |||
Details General patent policy Issues related to standard essential patents Issues related to anti-counterfeit policy, including anti-counterfeiting provisions in S.2226, the Senate-passed National Defense ... |
APPLE INC.
|
in-house lobbying |